272 related articles for article (PubMed ID: 11093803)
1. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
Ono T; Sato S; Kimura N; Tanaka M; Shibuya A; Old LJ; Nakayama E
Int J Cancer; 2000 Dec; 88(6):845-51. PubMed ID: 11093803
[TBL] [Abstract][Full Text] [Related]
2. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.
DeLeo AB; Shiku H; Takahashi T; John M; Old LJ
J Exp Med; 1977 Sep; 146(3):720-34. PubMed ID: 197192
[TBL] [Abstract][Full Text] [Related]
3. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.
Ono T; Kurashige T; Harada N; Noguchi Y; Saika T; Niikawa N; Aoe M; Nakamura S; Higashi T; Hiraki A; Wada H; Kumon H; Old LJ; Nakayama E
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3282-7. PubMed ID: 11248070
[TBL] [Abstract][Full Text] [Related]
4. Serological analysis of cell surface antigens on methylcholanthrene-induced mouse sarcomas with antisera produced against the tumors.
Tanimoto M; Takahashi T; Nishizuka Y
Gan; 1982 Apr; 73(2):184-92. PubMed ID: 6288499
[TBL] [Abstract][Full Text] [Related]
5. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
[TBL] [Abstract][Full Text] [Related]
6. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
Law LW
Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
[TBL] [Abstract][Full Text] [Related]
7. possible role of a retrovirus in the expression of tumor-specific antigens of the Meth A sarcoma.
DeLeo AB; Chang KS; Wivel NA; Appella E; Old LJ; Law LW
Int J Cancer; 1982 Jun; 29(6):687-93. PubMed ID: 7107069
[TBL] [Abstract][Full Text] [Related]
8. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
[TBL] [Abstract][Full Text] [Related]
9. Immunomic analysis of human sarcoma.
Lee SY; Obata Y; Yoshida M; Stockert E; Williamson B; Jungbluth AA; Chen YT; Old LJ; Scanlan MJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2651-6. PubMed ID: 12601173
[TBL] [Abstract][Full Text] [Related]
10. Antibody response of mice to chemically induced tumors.
Brown JP; Klitzman JM; Hellström I; Nowinski RC; Hellström KE
Proc Natl Acad Sci U S A; 1978 Feb; 75(2):955-8. PubMed ID: 204940
[TBL] [Abstract][Full Text] [Related]
11. Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.
Livingston PO; DeLeo AB; Jones M; Oettgen HF
J Immunol; 1983 Nov; 131(5):2601-5. PubMed ID: 6631013
[TBL] [Abstract][Full Text] [Related]
12. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
Coggin JH
Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
[TBL] [Abstract][Full Text] [Related]
13. Cell surface antigens of chemically induced fibrosarcomas: detection by a monoclonal antibody of a tumor-restricted Mr 12,000 protein gag antigen encoded by a dual-tropic murine leukemia virus.
Carbone G; Pierotti MA; Boiocchi M; De Leo AB; Ballinari D; Radice P; Borrello MG; Meseguer A; Cernuschi A; Parmiani G
Cancer Res; 1985 Oct; 45(10):4980-5. PubMed ID: 2992769
[TBL] [Abstract][Full Text] [Related]
14. Interferon treatment of murine Meth-A sarcoma cells: effects on the malignant phenotype and expression of tumor-specific and H-2 antigens.
Wivel NA; Pitha PM
Int J Cancer; 1982 Nov; 30(5):649-54. PubMed ID: 6185444
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a chemically homogeneous tumor antigen from a methylcholanthrene-induced sarcoma, Meth A.
Ullrich SJ; Robinson EA; Appella E
Mol Immunol; 1986 May; 23(5):545-55. PubMed ID: 3748014
[TBL] [Abstract][Full Text] [Related]
16. High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice.
Hopkins N; Besmer P; DeLeo AB; Law LW
Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7555-9. PubMed ID: 6950396
[TBL] [Abstract][Full Text] [Related]
17. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
[TBL] [Abstract][Full Text] [Related]
18. Properties of a M(r) 110,000 tumor rejection antigen of the chemically induced BALB/c Meth A sarcoma.
De Leo AB; Becker M; Lu L; Law LW
Cancer Res; 1993 Apr; 53(7):1602-7. PubMed ID: 7680955
[TBL] [Abstract][Full Text] [Related]
19. Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas.
Fritze D; Kern DH; Waldman SR; Pilch YH
Int J Cancer; 1975 Jan; 15(1):116-31. PubMed ID: 1079201
[TBL] [Abstract][Full Text] [Related]
20. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma.
Ali Eldib AM; Ono T; Shimono M; Kaneko M; Nakagawa K; Tanaka R; Noguchi Y; Nakayama E
Int J Cancer; 2004 Feb; 108(4):558-63. PubMed ID: 14696120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
